Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-06-13 @ 8:15 PM
Study NCT ID:
NCT06196918
Status:
RECRUITING
Last Update Posted:
2024-01-09
First Post:
2023-12-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NFEC-2023-314
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None